Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

BUY
$4.56 - $9.94 $5.35 Million - $11.7 Million
1,174,200 New
1,174,200 $8.77 Million
Q4 2021

Feb 08, 2022

SELL
$16.14 - $21.86 $6.08 Million - $8.24 Million
-377,000 Closed
0 $0
Q3 2021

Oct 28, 2021

BUY
$19.03 - $41.33 $7.17 Million - $15.6 Million
377,000 New
377,000 $8.68 Million

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.12B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Yong Rong (Hk) Asset Management LTD Portfolio

Follow Yong Rong (Hk) Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yong Rong (Hk) Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Yong Rong (Hk) Asset Management LTD with notifications on news.